CLINICAL-EVALUATION OF DOXACURIUM CHLORIDE

被引:9
作者
MADDINENI, VR
COOPER, R
STANLEY, JC
MIRAKHUR, RK
CLARKE, RSJ
机构
[1] QUEENS UNIV BELFAST,DEPT ANAESTHET,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND
[2] ROYAL VICTORIA HOSP,DEPT ANAESTHET,BELFAST BT12 6BA,NORTH IRELAND
关键词
NEUROMUSCULAR RELAXANTS; DOXACURIUM;
D O I
10.1111/j.1365-2044.1992.tb02322.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Doxacurium was administered to 50 adult patients for determination of potency (n = 10), onset and duration of clinical relaxation (n = 40). Cumulative dose‐response showed the ED95 to be 33.24 μg.kg−1 (95% confidence limits 27.4–39.3). Doxacurium 33 μg.kg−1 was then administered to four groups of 10 patients each who had anaesthesia maintained with either fentanyl‐droperidol or halothane and nerve stimulation carried out with single‐twitch stimulation at 0.1 Hz or train‐of‐four stimulation at 2 Hz every 12 s. The onset and duration showed wide individual variation. The mean (SD) times to occurrence of maximal block were 8.5 (4.6), 6.1 (1.9), 6.7 (1.8) and 4.7 (1.3) min in the single twitch‐fentanyl, train‐of‐four‐fentanyl, single twitch‐halothane and train‐of‐four‐halothane groups respectively, although it ranged from 3.4 to 13.1 min in individual patients. The mean (SD) durations of clinical relaxation (recovery of single twitch or first response in train‐of‐four to 25%) were 65 (22.8), 52 (21.7), 70 (33.4) and 72 (21.0) min respectively with individual values ranging from 31 to 103 min. Although halothane administration increased the duration of clinical relaxation and train‐of‐four stimulation accelerated the onset of effect, the changes due to these were not significant. There were no adverse effects on heart rate or indirectly measured arterial pressure. Copyright © 1992, Wiley Blackwell. All rights reserved
引用
收藏
页码:554 / 557
页数:4
相关论文
共 18 条
[1]  
ARMITAGE P, 1971, STATISTICAL METHODS, P349
[2]   CLINICAL-PHARMACOLOGY OF DOXACURIUM CHLORIDE - A NEW LONG-ACTING NONDEPOLARIZING MUSCLE-RELAXANT [J].
BASTA, SJ ;
SAVARESE, JJ ;
ALI, HH ;
EMBREE, PB ;
SCHWARTZ, AF ;
RUDD, GD ;
WASTILA, WB .
ANESTHESIOLOGY, 1988, 69 (04) :478-486
[3]  
BELL PF, 1988, BRIT J ANAESTHESIA, V60
[4]   ONSET AND RECOVERY OF ATRACURIUM AND SUXAMETHONIUM-INDUCED NEUROMUSCULAR BLOCKADE WITH SIMULTANEOUS TRAIN-OF-4 AND SINGLE TWITCH STIMULATION [J].
CURRAN, MJ ;
DONATI, F ;
BEVAN, DR .
BRITISH JOURNAL OF ANAESTHESIA, 1987, 59 (08) :989-994
[5]   HUMAN DOSE-RESPONSE CURVES FOR NEUROMUSCULAR BLOCKING-DRUGS - A COMPARISON OF 2 METHODS OF CONSTRUCTION AND ANALYSIS [J].
DONLON, JV ;
SAVARESE, JJ ;
ALI, HH ;
TEPLIK, RS .
ANESTHESIOLOGY, 1980, 53 (02) :161-166
[6]   NEW APPROACH TO STUDY OF FOUR NONDEPOLARIZING RELAXANTS IN MAN [J].
DONLON, JV ;
ALI, HH ;
SAVARESE, JJ .
ANESTHESIA AND ANALGESIA, 1974, 53 (06) :934-939
[7]  
EMMMOT RS, 1990, BRIT J ANAESTH, V65, P480
[8]  
GIBSON FM, 1987, EUR J ANAESTH, V4, P143
[9]   DOSE-RESPONSE RELATIONSHIPS OF DOXACURIUM CHLORIDE IN HUMANS DURING ANESTHESIA WITH NITROUS-OXIDE AND FENTANYL, ENFLURANE, ISOFLURANE, OR HALOTHANE [J].
KATZ, JA ;
FRAGEN, RJ ;
SHANKS, CA ;
DUNN, K ;
MCNULTY, B ;
RUDD, GD .
ANESTHESIOLOGY, 1989, 70 (03) :432-436
[10]   EXPERIMENTAL AND CLINICAL EXPERIENCES WITH A NEW MUSCLE RELAXANT RO 4-3816, DIALLYL-NOR-TOXIFERINE [J].
LUND, I ;
STOVNER, J .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1962, 6 (02) :85-&